United States:
Pharmaceutical Industry Antitrust Handbook
19 November 2018
Shearman & Sterling LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Associate Timothy Slattery (Antitrust-Washington, DC) has
contributed to the Pharmaceutical Industry Antitrust
Handbook (2nd Ed.) published by the American Bar Association.
Tim was Editor and Contributing Author to Chapter II
"Regulatory and Enforcement Framework" of the book.
The chapter covers subjects such as FDA drug approval
requirements, The Hatch-Waxman Act, government antitrust
enforcement, private suits and class actions relating to reverse
payment settlements, and government price regulation.
Purchase the Pharmaceutical Industry Antitrust
Handbook.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Antitrust/Competition Law from United States
US Antitrust Agencies Release Final Revised Merger Guidelines
Goodwin Procter LLP
On December 18, 2023, the Federal Trade Commission and the Antitrust Division of the Department of Justice released the final version of revised Merger Guidelines, a set of principles Agencies use in their review of mergers and acquisitions.
NCAA Updates Guidance On Transfer Rules
McLane Middleton, Professional Association
In December 2023, the State of Ohio sued the NCAA in the United States District Court for the District of West Virginia, challenging the organization's transfer waiver policy...